Study of Combined GARP:TGF-β1/PD-1 Blockade as a Shock-and-kill Strategy in HIV-1 Cure

Efficient mRNA delivery to resting T cells to reverse HIV latency

Phase 1 trial finds triple monoclonal antibody combination safe and effective for HIV-1 prevention

This phase 1, multicentre, randomised, open-label trial (HVTN 140/HPTN 101 part B) evaluated the safety, pharmacokinetics, and neutralisatio

Cette thérapie permet de transformer les cellules immunitaires en arme contre le cancer grâce à une injection chez la souris

<![CDATA[Functional Cure of Hepatitis B Infections Among Patients Coinfected With HIV]]>

HIV tri-specific killer engagers enhance NK cell function and expand NK cells in preclinical study

This article presents research on HIV tri-specific killer engagers (TriKEs) as a novel therapeutic approach to enhance natural killer (NK) c

Study reveals how immunotherapy can drive immune evasion in pancreatic cancer through Treg cell activity and MHC-I suppression

This study investigates mechanisms driving immunotherapy resistance in pancreatic ductal adenocarcinoma (PDA). Using murine models, the rese